ITCMDBv1
Clinical TrialID 7408

The Effect of Dihydroartemisinin in PCOS

NCT05465135

Polycystic Ovary Syndrome

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7408
Evidence Id
7408
Core Evidence Id
7408
Source Clinical Trial Id
7403
Herb2 Clinical Trial Id
HBCT007403
Nct Id
NCT05465135
Title
The Effect of Dihydroartemisinin in PCOS
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Polycystic Ovary Syndrome
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Dihydroartemisinin
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
Female
Age
Child, Adult
Enrollment
19
Outcome Measure
Recovery of regular menses by questionnaire, Periodical vaginal bleeding by questionnaire, 12 weeks|Bilateral ovary volume, Length, width and height of bilateral ovaries measured by B type ultrasound, 12 weeks|Number of immature follicles, Total number of follicles with diameters \<10 mm measured by B type ultrasound, 12 weeks|Serum testosterone levels, Measurement of serum total testosterone, 12 weeks
Sponsor Collaborator
Shanghai Zhongshan Hospital
Funded By
OTHER
Location
Zhongshan Hospital Fudan University, Shanghai, 200032, China
Other Id
B2020-115R
Start Date
2022-07-01
Primary Completion Date
2023-03-23
Completion Date
2023-04-23
First Posted
2022-07-19
Results First Posted
Last Update Posted
2024-05-17
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05465135
Title Cn
Title En
The Effect of Dihydroartemisinin in PCOS
Bilingual Status
semi_complete